Ask a Question

User bumpercard31

Member for: 1 day (since Jul 2)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/ykl5-124.html
About: Cycle Two study involving ceralasertib (AZD6738) together with durvalumab in patients using advanced/metastatic cancer that have hit a brick wall prior anti-PD1 treatment.

Activity by bumpercard31

Score: 100 points (ranked #2)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for bumpercard31

Please log in or register to post on this wall.
Mobile Phone Price list Sri Lanka
...